PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma

This study has been terminated.
(investigator letter from drug manufacturer stating animal studies showed increased risk of cancer which was an unknown adverse event)
Sponsor:
Information provided by (Responsible Party):
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT00240162
First received: October 13, 2005
Last updated: August 9, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2008
  Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)